Mumbai, Aug. 10 (PTI): The pharmaceutical industry has sought a dialogue on a central decision to bring over 100 more drugs under price control, doing so after its failure to get a stay from Delhi High Court on the move.
“Unless there is a dialogue with the authorities, we are going to run into these kind of issues again. These issues are not to be settled in courtrooms,” said an official of Organisation of Pharmaceutical Producers of India (OPPI), which had challenged the order.
Most of the 108 drugs listed in the July 10 order are used to treat diabetes and cardiovascular diseases. While Delhi High Court refused to entertain the OPPI’s petition, another plea by the Indian Pharmaceutical Alliance is pending in Bombay High Court.